ad 5075 has been researched along with Hyperglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, P; Berger, J; Biswas, C; Cullinan, CA; Doebber, TW; Hayes, NS; Leibowitz, MD; Saperstein, R; Smith, RG | 1 |
| Adams, AD; Berger, JP; Biswas, C; Doebber, TW; Elbrecht, A; Johnson, BA; Kelly, LJ; Macnaul, KL; Moller, DE; Mosley, R; Parikh, M; Petro, AE; Richards, K; Sharma, N; Surwit, RS; Tanen, MR; Thompson, GM; Ventre, J; Zhang, BB; Zhou, G | 1 |
2 other study(ies) available for ad 5075 and Hyperglycemia
| Article | Year |
|---|---|
Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
Topics: Animals; Blood Glucose; COS Cells; Cricetinae; Diabetes Mellitus; Hyperglycemia; Hypertriglyceridemia; Insulin Resistance; Male; Mice; Molecular Conformation; Peptide Hydrolases; Receptors, Cytoplasmic and Nuclear; Thiazoles; Transcription Factors; Triglycerides | 1996 |
Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
Topics: Adipocytes; Adipose Tissue; Animals; Cardiomegaly; Cells, Cultured; Gene Expression Regulation; Hyperglycemia; Indoles; Insulin Resistance; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Sulfides; Transcription Factors; Weight Gain | 2003 |